Summary
The hypotensive actions of metoprolol and alpha-methyldopa have been compared in 37 men with previously untreated essential hypertension; 36 belonged to stage 1 and 1 to stage 2 of the WHO classification. After four weeks of placebo treatment the patients were randomly allocated to treatment with either of the two drugs. Treatment was started with metoprolol 75 mg daily or alpha-methyldopa 375 mg and was doubled after eight weeks. Satisfactory blood pressure control was defined as systolic blood pressure below 160 mm Hg and diastolic below 95 mm Hg. The patients were examined every four weeks and in those with unsatisfactory control the dose was gradually increased up to a maximum daily dose of metoprolol 450 mg or alpha-methyldopa 2250 mg. The trial lasted for 24 weeks after randomization. Five patients dropped out of the study. After six months, satisfactory blood pressure control was recorded in 16 out of 17 patients and 14 out of 15 patients treated with metoprolol and alpha-methyldopa, respectively. The average reduction in blood pressure produced by the two drugs was comparable. One patient in the alpha-methyldopa group developed drug exanthema and two patients a positive Coombs' test. Other side effects were few and did not differ between the two compounds.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Åblad, B., Carlsson, E., Ek, L.: Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists. Life Sci.12, 107–119 (1973)
Bengtsson, C.: Comparison between metoprolol and propranolol as anti-hypertensive agents. A double-blind crossover study. Acta med. scand.199, 71–74 (1976)
Bengtsson, C.: The effect of metoprolol — a new selective adrenergic beta1-receptor blocking agent in mild hypertension. Acta med. scand.199, 65–70 (1976)
Brahm, M.: Comparison between propranolol and methyldopa in the treatment of hypertension. A double-blind trial. Ugeskr. Læg.135, 974–976 (1973)
Dollery, C.T.: Alpha-methyldopa in the treatment of hypertension. Med. Clin. N. Amer.48, 335–345 (1964)
Dustan, H.P., Smith, W.H.: Arterial pressure responses to discontinuing anti-hypertensive drugs. Circulation37, 370–379 (1968)
Hamilton, M.: Some aspects of the long-term treatment of severe hypertension with methyldopa. Postgrad. med. J.44, 66–69 (1968)
Hansson, L., Malmcrona, R., Olander, R., Rosenhall, L., Westerlund, A., Åberg, H., Hood, B.: Propranolol in hypertension. Report on 158 patients treated up to one year. Klin. Wschr.50, 364–369 (1972)
Hansson, L., Westerlund, A., Åberg, H., Karlberg, E.E.: A comparison of the antihypertensive effect of atenolol (ICI 66082) and propranolol. Europ. J. clin. Pharmacol.9, 361–365 (1976)
Howwitz, D., Pettinger, W.A., Orvis, H., Sjoerdsma, A.: Effects of methyldopa in fifty hypertensive patients. Clin. Pharmacol. Ther.8, 224–234 (1976)
Johnsson, G.: The effect of the β-adrenergic blocker alprenolol in hypertension. Acta med. scand. Suppl.554, 1–62 (1974)
Johnsson, G.: Influence of metoprolol and propranolol on hemodynamic effects induced by adrenaline and physical work. Acta pharmacol. (Kbh.)36, Suppl.V, 59–68 (1975)
Oates, J.A., Gillespie, L., Udenfriend, S., Sjoersdsma, A.: Decarboxylase inhibition and blood pressure reduction by alphamethyl 3, 4-dihydroxy-DL-phenylalanine. Science131, 1890–1891 (1960)
Onesti, G., Brest, A.N., Novack, P., Moyer, J.H.: Pharmacodynamic effects and clinical use of alpha methyldopa in the treatment of essential hypertension. Amer. J. Cardiol.9, 863–867 (1962)
Prichard, B.N.C., Gillam, P.M.S.: Propranolol in hypertension. Amer. J. Cardiol.18, 387–391 (1966)
Smirk, H.: Hypotensive action of methyldopa. Brit. med. J.1963 I, 146–151
Tarazi, R.C., Dustan, H.P., Frohlich, E.D.: Long-term thiazide therapy in essential hypertension. Circulation41, 709–717 (1970)
Thurm, R.H., Smith, W.H.: On resetting of “barostats” in hypertensive patients. J. Amer. med. Ass.201, 85–88 (1967)
Tibblin, G., Åblad, B.: Antihypertensive therapy with alprenolol, a beta-adrenergic receptor antagonist. Acta med. scand.186, 451–457 (1969)
Tuomilehto, J., Puska, P., Mustaniemi, H.: A comparative study of alprenolol and alpha-methyldopa respectively in combination with chlorthalidone in hypertension. Acta med. scand. Suppl.554, 47–54 (1974)
Vedin, J.A., Wilhelmsson, C.E., Werkö, L.: Comparative study of alprenolol and methyldopa in previously untreated essential hypertension. Brit. Heart J.35, 1285–1292 (1973)
Zacharias, F.J., Cowen, K.J., Prestt, J., Vickers, J., Wall, B.: Propranolol in hypertension. A study of long-term therapy, 1964–1970. Amer. Heart J.83, 755–761 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bergstrand, R.H., Vedin, J.A., Wilhelmsson, C.E. et al. Comparative study of metoprolol and alpha-methyldopa in untreated essential hypertension. Eur J Clin Pharmacol 10, 375–379 (1976). https://doi.org/10.1007/BF00563072
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00563072